BRAF and melanoma: Aiming to avoid collateral Cu toxicity, our earlier study aimed to augment Cu chelator without exogenous Cu supplementation [26] using wt p53 C8161 melanoma cells lacking the V600E BRAF mutation compared to wt p53 A375 human melanoma harbouring this typical BRAF oncogenic mutation [26].